Life Science News

24 June 2003 - Coley wins $6m DARPA contract for vaccine enhancement

Contract to develop CpG immunostimulatory TLR9 agonists for enhancement of vaccines brings total of $12m for DARPA contracts awarded to Coley Pharmaceutical..  More >>

24 June 2003 - 'End opposition' to biotech urges Bush at BIO Convention

Biotech "key to fighting global hunger, terrorism" - Bush President Bush yesterday urged governments to "end their opposition" to biotechnology in order to..  More >>

24 June 2003 - Cambrex opens new biopharmaceutical process development facility

Cambrex Bio Science offers complete optimization  for early-stage biomanufacturing development Cambrex Bio Science Baltimore, Inc. unveiled its new..  More >>

23 June 2003 - Biogen & Idec to merge forging $1.5bn pa Big Biopharma player

Idec Pharmaceutical Corporation and Biogen sign definitive merger deal worth $6.8 bn, will form combined company named Biogen Idec Inc. With major..  More >>

23 June 2003 - Inpharmatica to acquire development capability in metabolism

Deal with ArQule Inc. to take over Cambridge, UK site will give Inpharmatica capabilities in drug disposition (absorption, distribution, metabolism, and..  More >>

23 June 2003 - New containment facility for high potency API development

Solutia Pharmaceutical Services Division (Solutia PSD) completes containment facility in Bubendorf, Switzerland. The facility supports Solutia’s newest Centre..  More >>

23 June 2003 - Avant Immunotherapeutics rejigs CholeraGarde vaccine production

Avant Immunotherapeutics, Inc. based in Needham, Mass is terminating its manufacturing contract with Bio Sidus, S.A., of Buenos Aires, Argentina, for the..  More >>

20 June 2003 - Inpharmatica achieves first milestone for secreted protein discovery

Collaboration with Serono generates milestone payment for novel protein with potential therapeutic activity. London, UK’s Inpharmatica Ltd has received its..  More >>

20 June 2003 - Painless end for a JV - CeNeS/Elan

CeNeS Pharmaceuticals plc has reached agreement with Elan Corporation plc to terminate the CeNeS/Elan joint venture, to develop morphine-6-glucoronide (M6G)..  More >>

19 June 2003 - Safer smallpox vaccine delivered two months early

Bavarian Nordic manufactures and releases MVA-BN to US Government two months ahead of schedule As part of the US Government’s program to develop a safe..  More >>

19 June 2003 - Bleak future at home of Dolly the Sheep

Bayer pulls out of project to commercialise PPL’s treatment hope for cystic fibrosis The future of PPL Therapeutics, based in Edinburgh, appears to be in the..  More >>

18 June 2003 - Pharming outsources production of recombinant C1 inhibitor for HAE to DSM

Netherlands based companies sign commercial manufacturing contract aimed at providing material for treatment of patients with hereditary angioedema. Pharming..  More >>